NJ S1614 | 2022-2023 | Regular Session
Status
Completed Legislative Action
Spectrum: Partisan Bill (Democrat 14-0)
Status: Passed on July 10 2023 - 100% progression
Action: 2023-07-10 - Approved P.L.2023, c.105.
Text: Latest bill text (Chaptered) [HTML]
Spectrum: Partisan Bill (Democrat 14-0)
Status: Passed on July 10 2023 - 100% progression
Action: 2023-07-10 - Approved P.L.2023, c.105.
Text: Latest bill text (Chaptered) [HTML]
Summary
Requires health insurance carriers to provide coverage for epinephrine auto-injector devices and asthma inhalers; limits cost sharing for health insurance coverage of insulin.
Title
Requires health insurance carriers to provide coverage for epinephrine auto-injector devices and asthma inhalers; limits cost sharing for health insurance coverage of insulin.
Sponsors
Roll Calls
2023-06-30 - Senate - Senate Floor: Concur in Assembly Amendments (Y: 35 N: 0 NV: 5 Abs: 0) [PASS]
2023-06-30 - Assembly - Assembly Floor: Third Reading - Final Passage (Y: 77 N: 1 NV: 2 Abs: 0) [PASS]
2023-06-30 - Assembly - Assembly Floor: Substitute for A2839 (Voice Vote) (Y: 0 N: 0 NV: 0 Abs: 0) [PASS]
2023-06-27 - Assembly - Assembly Budget Committee: Reported with Amendments (Y: 15 N: 0 NV: 0 Abs: 0) [PASS]
2023-06-22 - Assembly - Assembly Appropriations Committee: Reported Favorably (Y: 10 N: 1 NV: 0 Abs: 0) [PASS]
2022-06-29 - Senate - Senate Floor: Third Reading - Final Passage (Y: 40 N: 0 NV: 0 Abs: 0) [PASS]
2022-06-27 - Senate - Senate Budget and Appropriations Committee: Reported with Amendments (Y: 12 N: 0 NV: 0 Abs: 0) [PASS]
2022-03-14 - Senate - Senate Commerce Committee: Reported Favorably (Y: 4 N: 0 NV: 1 Abs: 0) [PASS]
2023-06-30 - Assembly - Assembly Floor: Third Reading - Final Passage (Y: 77 N: 1 NV: 2 Abs: 0) [PASS]
2023-06-30 - Assembly - Assembly Floor: Substitute for A2839 (Voice Vote) (Y: 0 N: 0 NV: 0 Abs: 0) [PASS]
2023-06-27 - Assembly - Assembly Budget Committee: Reported with Amendments (Y: 15 N: 0 NV: 0 Abs: 0) [PASS]
2023-06-22 - Assembly - Assembly Appropriations Committee: Reported Favorably (Y: 10 N: 1 NV: 0 Abs: 0) [PASS]
2022-06-29 - Senate - Senate Floor: Third Reading - Final Passage (Y: 40 N: 0 NV: 0 Abs: 0) [PASS]
2022-06-27 - Senate - Senate Budget and Appropriations Committee: Reported with Amendments (Y: 12 N: 0 NV: 0 Abs: 0) [PASS]
2022-03-14 - Senate - Senate Commerce Committee: Reported Favorably (Y: 4 N: 0 NV: 1 Abs: 0) [PASS]
History
| Date | Chamber | Action |
|---|---|---|
| 2023-07-10 | Senate | Approved P.L.2023, c.105. |
| 2023-06-30 | Senate | Passed Senate (Passed Both Houses) (35-0) |
| 2023-06-30 | Senate | Received in the Senate, 2nd Reading on Concurrence |
| 2023-06-30 | Assembly | Passed by the Assembly (77-1-0) |
| 2023-06-30 | Assembly | Substituted for A2839 (2R) |
| 2023-06-27 | Assembly | Reported out of Assembly Comm. with Amendments, 2nd Reading |
| 2023-06-27 | Assembly | Recommitted to Assembly Budget Committee |
| 2023-06-22 | Assembly | Reported out of Assembly Committee, 2nd Reading |
| 2022-06-29 | Assembly | Received in the Assembly, Referred to Assembly Appropriations Committee |
| 2022-06-29 | Senate | Passed by the Senate (40-0) |
| 2022-06-27 | Senate | Reported from Senate Committee with Amendments, 2nd Reading |
| 2022-03-14 | Senate | Referred to Senate Budget and Appropriations Committee |
| 2022-03-14 | Senate | Reported from Senate Committee, 2nd Reading |
| 2022-02-14 | Senate | Introduced in the Senate, Referred to Senate Commerce Committee |
Same As/Similar To
A2839 (Same As) 2023-06-30 - Substituted by S1614 (2R)
